Alaunos Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Alaunos Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q4 2023.
  • Alaunos Therapeutics, Inc. Operating Lease, Payments for the quarter ending November 15, 2023 was $100K.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $400K, a 50% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $800K, a 38.5% decline from 2021.
  • Alaunos Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.3M, a 30% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $100K Nov 15, 2023 10-K 2024-04-01
Q1 2019 $178K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.